Qantas Airways announced it will shut down its Singapore-based budget airline Jetstar Asia by July 31, citing escalating supplier costs, high airport charges, and growing competition in the region. The closure will affect up to 500 jobs, and Jetstar Asia’s fleet of 13 Airbus A320s will be reassigned to operations in Australia and New Zealand.
The decision comes as low-cost rivals like Scoot (Singapore Airlines), AirAsia, and VietJet expand their post-pandemic capacities, intensifying price competition and pressuring margins. Jetstar Asia, which served 16 routes across Asia from Singapore’s Changi Airport, has struggled to match returns from Qantas’ core markets.
Qantas Group CEO Vanessa Hudson said some of Jetstar Asia’s supplier costs have surged by up to 200%, significantly impacting the airline’s cost structure. The carrier is projected to post an underlying EBIT loss of A$35 million (USD $22.76 million) for the financial year ending June 30.
The closure is expected to unlock up to A$500 million in value, which Qantas will reinvest in its core businesses, including replacing expensive leased aircraft currently used by Jetstar Airways in Australia. Affected customers will receive full refunds or be rebooked on other airlines. Employees will be offered redundancy packages and employment support, including opportunities within the Qantas group or with other carriers.
Operations at Qantas’ other low-cost subsidiaries—Jetstar Airways in Australia and Jetstar Japan—will continue unaffected. Jetstar Asia had operated in the region for 20 years but faced mounting operational and financial challenges in recent years, leading to this strategic retreat.
The move highlights the ongoing pressure on regional budget airlines as they navigate cost inflation and post-COVID market shifts.


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Instagram Outage Disrupts Thousands of U.S. Users
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



